位置:首页 > 蛋白库 > PA2H_DEIAC
PA2H_DEIAC
ID   PA2H_DEIAC              Reviewed;         138 AA.
AC   O57385; Q8UVZ5;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   25-MAY-2022, entry version 96.
DE   RecName: Full=Basic phospholipase A2 homolog acutohaemolysin {ECO:0000303|PubMed:10930841, ECO:0000303|PubMed:12871974};
DE            Short=svPLA2 homolog;
DE   AltName: Full=Dac-K49 {ECO:0000303|PubMed:11594738};
DE   Flags: Precursor;
OS   Deinagkistrodon acutus (Hundred-pace snake) (Agkistrodon acutus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Crotalinae; Deinagkistrodon.
OX   NCBI_TaxID=36307;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=10084123; DOI=10.1016/s1050-3862(98)00033-3;
RA   Fan C.Y., Qian Y.C., Yang S.L., Gong Y.;
RT   "cDNA cloning and sequence analysis of Lys-49 phospholipase A2 from
RT   Agkistrodon acutus.";
RL   Genet. Anal. 15:15-18(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=11594738; DOI=10.1006/abbi.2001.2524;
RA   Tsai I.-H., Chen Y.-H., Wang Y.-M., Tu M.-C., Tu A.T.;
RT   "Purification, sequencing, and phylogenetic analyses of novel Lys-49
RT   phospholipases A(2) from the venoms of rattlesnakes and other pit vipers.";
RL   Arch. Biochem. Biophys. 394:236-244(2001).
RN   [3]
RP   PROTEIN SEQUENCE OF 17-27, SUBUNIT, MASS SPECTROMETRY, CRYSTALLIZATION, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=10930841; DOI=10.1107/s0907444900005643;
RA   Huang Q.-Q., Zhu X.-Y., Li N., Deng W.-H., Chen T.-B., Rao P.-F.,
RA   Teng M.-K., Niu L.-W.;
RT   "Characterization, crystallization and preliminary X-ray diffraction
RT   analysis of acutohaemolysin, a haemolytic toxin from Agkistrodon acutus
RT   venom.";
RL   Acta Crystallogr. D 56:907-911(2000).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 17-138, SUBUNIT, AND DISULFIDE
RP   BONDS.
RC   TISSUE=Venom;
RX   PubMed=12871974; DOI=10.1074/jbc.m305210200;
RA   Liu Q., Huang Q.-Q., Teng M.-K., Weeks C.M., Jelsch C., Zhang R.,
RA   Niu L.-W.;
RT   "The crystal structure of a novel, inactive, lysine 49 PLA2 from
RT   Agkistrodon acutus venom: an ultrahigh resolution, AB initio structure
RT   determination.";
RL   J. Biol. Chem. 278:41400-41408(2003).
CC   -!- FUNCTION: Snake venom phospholipase A2 homolog that lacks enzymatic
CC       activity (PubMed:10930841). Is myotoxic (By similarity). Has a strong
CC       indirect hemolytic activity and anticoagulant activity
CC       (PubMed:10930841). A model of myotoxic mechanism has been proposed: an
CC       apo Lys49-PLA2 is activated by the entrance of a hydrophobic molecule
CC       (e.g. fatty acid) at the hydrophobic channel of the protein leading to
CC       a reorientation of a monomer (By similarity). This reorientation causes
CC       a transition between 'inactive' to 'active' states, causing alignment
CC       of C-terminal and membrane-docking sites (MDoS) side-by-side and
CC       putting the membrane-disruption sites (MDiS) in the same plane, exposed
CC       to solvent and in a symmetric position for both monomers (By
CC       similarity). The MDoS region stabilizes the toxin on membrane by the
CC       interaction of charged residues with phospholipid head groups (By
CC       similarity). Subsequently, the MDiS region destabilizes the membrane
CC       with penetration of hydrophobic residues (By similarity). This
CC       insertion causes a disorganization of the membrane, allowing an
CC       uncontrolled influx of ions (i.e. calcium and sodium), and eventually
CC       triggering irreversible intracellular alterations and cell death (By
CC       similarity). {ECO:0000250|UniProtKB:I6L8L6,
CC       ECO:0000269|PubMed:10930841}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10930841,
CC       ECO:0000269|PubMed:12871974}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:10930841}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:10930841}.
CC   -!- MASS SPECTROMETRY: Mass=13938; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:10930841};
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II subfamily.
CC       K49 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not bind calcium as one of the calcium-binding sites is
CC       lost (Asp->Lys in position 64, which corresponds to 'Lys-49' in the
CC       current nomenclature). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ223188; CAA11159.1; -; mRNA.
DR   EMBL; AF269132; AAL36975.1; -; mRNA.
DR   PDB; 1MC2; X-ray; 0.85 A; A=17-138.
DR   PDB; 1MG6; X-ray; 1.60 A; A=17-138.
DR   PDBsum; 1MC2; -.
DR   PDBsum; 1MG6; -.
DR   AlphaFoldDB; O57385; -.
DR   SMR; O57385; -.
DR   EvolutionaryTrace; O57385; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Myotoxin;
KW   Secreted; Signal; Toxin.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:10930841"
FT   CHAIN           17..138
FT                   /note="Basic phospholipase A2 homolog acutohaemolysin"
FT                   /id="PRO_0000022774"
FT   REGION          121..133
FT                   /note="Important for membrane-damaging activities in
FT                   eukaryotes and bacteria; heparin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P24605"
FT   SITE            121
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            124
FT                   /note="Important residue of the cationic membrane-docking
FT                   site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            127
FT                   /note="Hydrophobic membrane-disruption site (MDiS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            128
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   SITE            133
FT                   /note="Cationic membrane-docking site (MDoS)"
FT                   /evidence="ECO:0000250|UniProtKB:I6L8L6"
FT   DISULFID        42..131
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        44..60
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        59..111
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        65..138
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        66..104
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        73..97
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   DISULFID        91..102
FT                   /evidence="ECO:0000269|PubMed:12871974,
FT                   ECO:0007744|PDB:1MC2, ECO:0007744|PDB:1MG6"
FT   CONFLICT        130
FT                   /note="S -> L (in Ref. 2; AAL36975)"
FT                   /evidence="ECO:0000305"
FT   HELIX           18..29
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           33..37
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   TURN            41..43
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   STRAND          44..47
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           55..67
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   STRAND          71..73
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   STRAND          82..85
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           96..114
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           115..118
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:1MC2"
FT   HELIX           128..130
FT                   /evidence="ECO:0007829|PDB:1MC2"
SQ   SEQUENCE   138 AA;  15777 MW;  1353CD8C8F54DA99 CRC64;
     MRALWIVAVL LVGVEGSLFE LGKMIWQETG KNPVKNYGLY GCNCGVGGRG EPLDATDRCC
     FVHKCCYKKL TDCDSKKDRY SYKWKNKAIV CGKNQPCMQE MCECDKAFAI CLRENLDTYN
     KSFRYHLKPS CKKTSEQC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024